Abstract
The process fails to improve the evidence after early licensing Like other expedited procedures for early marketing authorisation, conditional approval12 stems from the assumption that immediate availability of new drugs...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
